Symptomatic Focal Vitreomacular Adhesion

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-07-18
Clinical Trial Update: A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion [Phase 2]
Phase 2 trial update for Alg-1001 in symptomatic focal vitreomacular adhesion has completed with results posted.